The Ohio State Universitty Wexner Medical Center
Columbus, Ohio, 43214, United States
NCT Number: NCT05695430
The purpose of this study is to examine the effectiveness of a psychotherapy (non-medication) treatment, Brief Cognitive Behavioral Therapy for Suicide Prevention, in reducing suicide ideation and attempts for people with physical disabilities.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Columbus, Ohio, 43214, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
12 sessions of of Brief Cognitive Behavioral Therapy that has been adapted for people with physical disabilities will be administered through telehelath.
Time frame: Weekly change through treatment completion, an average of 3 months
Past-week suicidal ideation severity
Time frame: Through treatment completion, an average of 3 months
Suicide attempt since last assessment
Ohio State University
Other
Telehealth-delivered Brief Cognitive Behavioral Therapy to Prevent Suicides in People With Physical Disabilities
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05282225
Behavior, Behavioral Symptoms
Ann Arbor, Michigan, United States
View Trial DetailsNCT05202756
Behavior, Behavioral Symptoms
Providence, Rhode Island, United States
View Trial DetailsNCT05427734
Alcohol Abuse, Alcohol Use Disorder
Seattle, Washington, United States
View Trial DetailsNCT04140149
Behavior, Behavioral Symptoms
Winnipeg, Manitoba, Canada
View Trial Details